Tuberculosis and pneumonia in HIV-infected children: an overview

Helena Rabie1,2,3, Pierre Goussard1

  • 1Department of Pediatrics and Child Health, University of Stellenbosch and Tygerberg Academic Hospital, Cape Town, South Africa.

Insights

Pneumonia is a major cause of child death. HIV-infected children face higher risks for respiratory infections, including tuberculosis, even as HIV transmission decreases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Pneumonia is a leading cause of death in young children globally.
  • Children with human immunodeficiency virus (HIV) have a high burden of lower respiratory tract infections (LRTIs).
  • Opportunistic pathogens like Pneumocystis jirovecii and cytomegalovirus are significant concerns in HIV-infected children.

Purpose of the Study:

  • To review the impact of tuberculosis and other LRTIs on HIV-infected infants and children.
  • To discuss the changing epidemiology of respiratory infections in HIV-infected children.
  • To explore the increased vulnerability of HIV-exposed but uninfected infants to respiratory pathogens.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of epidemiological trends in pediatric respiratory infections.
  • Discussion of immunological factors contributing to increased susceptibility.

Main Results:

  • HIV-infected children experience a disproportionate burden of LRTIs, including bacterial, viral, and tuberculous infections.
  • Antiretroviral therapy and reduced vertical HIV transmission are altering infection patterns, but risks remain elevated.
  • HIV-exposed but uninfected infants may possess immune deficits increasing their susceptibility to respiratory pathogens.

Conclusions:

  • Despite advances in HIV management, HIV-infected children remain at high risk for severe respiratory infections.
  • Understanding the specific vulnerabilities of HIV-exposed and HIV-infected infants is crucial for targeted interventions.
  • Further research into the immune deficits of HIV-exposed infants is needed to mitigate respiratory risks.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
977
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
686